fosmanogepix (APX001) - Basilea
Fusarium solani Skin and Soft Tissue Infection in a Patient With Chronic Sclerosing Skin Graft-vs-Host Disease: A Case Report. (PubMed, Am J Case Rep) - Aug 29, 2026 - "In addition, this case outlines the high complexity of fusariosis treatment due to the capacity of this organism to develop multi-drug-resistance to mainline antifungals. This report illustrates clinical and radiographic improvement following implementation of fosmanogepix therapy in a severely immunocompromised patient with GVHD and complex multi-drug-resistant Fusarium infection." 
Journal • Chronic Graft versus Host Disease • Dermatology • Graft versus Host Disease • Immunology • Infectious Disease • Scleroderma • Systemic Sclerosis • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42661363
 
Hanaa I Hussain; Jamie Caracciolo; Nathan J Parker; Olga Klinkova; Rod Quilitz
 
Aug 29, 2026
 
Prev Next